26.02.2010

Event: New Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of DDI

An international Workshop on "New Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions" will take place from May 31th to June 1st  at the beautiful location of the "Marbach Castel", Lake Constance, Germany.

This event is organized by Exalon partners cr.appliance and will combine a regulatory update on the investigation of Drug-Drug-Interactions (DDIs) from the European perspective with a scientific update on the investigation of DDIs. Four sessions comprising a 'regulatory update', 'metabolic drug-drug interactions (mDDI)', 'non-metabolic DDIs & PGx of DDIs', and 'tools in design & evaluation of DDI-trials for better timing of DDI-trials in course of clinical development' will address the latest knowledge and strategies in this key area of drug development. Commonalities and differences between US and EU regulatory requirements in conducting DDI studies will also be addressed.

Registration is possible online on the cr.appliance website.

Download Program Flyer

[Source: cr.appliance]

© 2007 - 2018 | Exalon GmbH | Fritz-Reichle-Ring 2 | 78315 Radolfzell | Germany | Phone: +49 (0)7732.939.1650 | Fax: -.1655 | e-Mail:info@exalon.com